phenylalanine and Albuminuria

phenylalanine has been researched along with Albuminuria in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Bjornstad, P; Cherney, DZ; D'Alessandro, A; Heerspink, H; Li, LP; Nadeau, KJ; Nelson, RG; Pavkov, ME; Piani, F; Prasad, P; Pyle, L; Reisz, JA; van Raalte, DH; Vigers, T; Vinovskis, C	1
Barazzoni, R; Kiwanuka, E; Tessari, P; Vedovato, M; Vettore, M; Zanetti, M	1
Califf, RM; Giles, T; Haffner, SM; Hernandez, AF; Krum, H; Leiter, LA; Martinez, FA; Mazzone, T; McMurray, JJ; Rutten, GE; Standl, E; Sun, JL; Thomas, L; Tognoni, G; Wong, YW	1

Trials

2 trial(s) available for phenylalanine and Albuminuria

Article	Year
Plasma levels of carboxylic acids are markers of early kidney dysfunction in young people with type 1 diabetes. Pediatric nephrology (Berlin, Germany), 2023, Volume: 38, Issue:1 Topics: Adolescent; Albuminuria; Carboxylic Acids; Diabetes Mellitus, Type 1; Fumarates; Glomerular Filtration Rate; Glycine; Histidine; Humans; Kidney; Malates; Phenylalanine; Renal Insufficiency	2023
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study. Circulation. Heart failure, 2013, Volume: 6, Issue:2 Topics: Adiposity; Aged; Albuminuria; Biomarkers; Blood Glucose; Creatinine; Cyclohexanes; Double-Blind Method; Female; Glucose Metabolism Disorders; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Incidence; Linear Models; Male; Middle Aged; Multivariate Analysis; Nateglinide; Nonlinear Dynamics; Obesity, Abdominal; Phenylalanine; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Waist Circumference	2013

Article

Year

Plasma levels of carboxylic acids are markers of early kidney dysfunction in young people with type 1 diabetes.

Pediatric nephrology (Berlin, Germany), 2023, Volume: 38, Issue:1

Topics: Adolescent; Albuminuria; Carboxylic Acids; Diabetes Mellitus, Type 1; Fumarates; Glomerular Filtration Rate; Glycine; Histidine; Humans; Kidney; Malates; Phenylalanine; Renal Insufficiency

2023

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.

Circulation. Heart failure, 2013, Volume: 6, Issue:2

Topics: Adiposity; Aged; Albuminuria; Biomarkers; Blood Glucose; Creatinine; Cyclohexanes; Double-Blind Method; Female; Glucose Metabolism Disorders; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Incidence; Linear Models; Male; Middle Aged; Multivariate Analysis; Nateglinide; Nonlinear Dynamics; Obesity, Abdominal; Phenylalanine; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Waist Circumference

2013

Other Studies

1 other study(ies) available for phenylalanine and Albuminuria

Article	Year
Accelerated whole-body protein catabolism in subjects with type 2 Diabetes Mellitus and albuminuria. PloS one, 2020, Volume: 15, Issue:12 Topics: Adult; Albuminuria; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Phenylalanine; Protein Biosynthesis; Proteolysis	2020